[ivanonymous]

Besides close monitoring of people on O2 to adjust amounts and intubate if that time comes, there are potentially other components of supportive care that might alter outcomes, like IV anti-virals (e.g. remdesivir) or anti-coagulants, e.g. heparin. Some anti-coagulants can be given at home, but the strong doses being discussed also come with high risk of bleeding, benefitting from bed rest and close observation. For a good slice of the sickest COVID patients, hospitalization is helpful and hard to replicate at home, even with our limited therapies.

That said, oxygen and heparin at home could be good for a lot of patients. Improvements in prognostication may help distinguish that group in the future.